Selected Publications

Academic Article

Year Title Altmetric
2022 B-assembler: a circular bacterial genome assemblerBMC Genomics.  23. 2022
2022 Omadacycline Is Highly Active in Vitro against Mycoplasma genitaliumMicrobiology Spectrum.  10. 2022
2022 Antimicrobial susceptibilities and mechanisms of resistance of commensal and invasive Mycoplasma salivarium isolatesFrontiers in Microbiology.  13. 2022
2022 Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacinJournal of Global Antimicrobial Resistance.  29:434-443. 2022
2022 A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteriaFuture Microbiology.  17:397-410. 2022
2022 Randomized trial of azithromycin to eradicate Ureaplasma respiratory colonization in preterm infants: 2-year outcomesPediatric Research.  91:178-187. 2022
2021 Lefamulin in patients with community-acquired bacterial pneumonia caused by atypical respiratory pathogens: Pooled results from two phase 3 trialsAntibiotics.  10. 2021
2021 Trichomonas vaginalis detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV/MG testJournal of Clinical Microbiology.  59. 2021
2021 Mycoplasma genitalium Infection in Young Women Without Urogenital Symptoms Presenting to a Community-Based Emergency Department in Birmingham, AlabamaSexually Transmitted Diseases.  48:e27-e29. 2021
2021 Septic polyarthritis with Mycoplasma salivarium in a patient with common variable immunodeficiency: case report and review of the literature.Access Microbiology.  3:000221. 2021
2020 Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants 2020
2020 Hyperammonemia syndrome due to Ureaplasma urealyticum in a kidney transplant recipient: A case of disseminated disease from a fluoroquinolone-resistant isolateTransplant Infectious Disease.  22. 2020
2020 Macrolide-resistant Mycoplasma pneumoniae pneumonia in transplantation: Increasingly typical?Transplant Infectious Disease.  22. 2020
2020 Molecular characterization of Mycoplasma pneumoniae isolates in the United States from 2012 to 2018Journal of Clinical Microbiology.  58. 2020
2020 In vitro activities of eravacycline and other antimicrobial agents against human mycoplasmas and ureaplasmasAntimicrobial Agents and Chemotherapy.  64. 2020
2020 Evaluation of commercial molecular diagnostic methods for detection and determination of macrolide resistance in mycoplasma pneumoniaeJournal of Clinical Microbiology.  58. 2020
2020 Mycoplasma genitalium detection in urogenital specimens from symptomatic and asymptomatic men and women by use of the cobas TV/MG testJournal of Clinical Microbiology.  58. 2020
2019 Mycoplasma genitalium Coinfection in Women With Chlamydia trachomatis InfectionSexually Transmitted Diseases.  46:E101-E104. 2019
2019 Evaluation of the ELITe InGenius PCR platform for detection of Mycoplasma pneumoniaeJournal of Clinical Microbiology.  57. 2019
2019 Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocyclineInternational Journal of STD and AIDS.  30:512-514. 2019
2019 Allergic airway sensitization impairs antibacterial IgG antibody responses during bacterial respiratory tract infectionsJournal of Allergy and Clinical Immunology.  143:1183-1197.e7. 2019
2019 Azithromycin-based Extended-Spectrum Antibiotic Prophylaxis for Cesarean: Role of Placental Colonization with Genital Ureaplasmas and MycoplasmasAmerican Journal of Perinatology.  36:1002-1008. 2019
2019 Macrolide-resistant mycoplasma pneumoniae in the United States as determined from a national surveillance programJournal of Clinical Microbiology.  57. 2019
2019 Mycoplasma genitalium infections with macrolide and fluoroquinolone resistance-Associated mutations in heterosexual african American couples in AlabamaSexually Transmitted Diseases.  46:18-24. 2019
2019 Mycoplasma pneumoniae Carriage with De Novo Macrolide-Resistance and Breakthrough PneumoniaPediatrics.  144. 2019
2018 In vitro activities of the benzoquinolizine fluoroquinolone levonadifloxacin (WCK 771) and other antimicrobial agents against mycoplasmas and ureaplasmas in humans, including isolates with defined resistance mechanismsAntimicrobial Agents and Chemotherapy.  62. 2018
2018 A rapid and simple chemical method for the preparation of Ag colloids for surface-enhanced Raman spectroscopy using the Ag mirror reactionVibrational Spectroscopy.  98:1-7. 2018
2018 Is retained bone debris in cannulated orthopedic instruments sterile after autoclaving?American Journal of Infection Control.  46:1009-1013. 2018
2018 Evaluation of a real-time PCR assay for detection of Mycoplasma genitalium and macrolide resistance-mediating mutations from clinical specimensDiagnostic Microbiology and Infectious Disease.  91:123-125. 2018
2018 High prevalence of multidrug-resistant mycoplasma genitalium in human immunodeficiency virus-infected men who have sex with men in AlabamaClinical Infectious Diseases.  66:796-798. 2018
2018 Analysis of the tonsillar microbiome in young adults with sore throat reveals a high relative abundance of Fusobacterium necrophorum with low diversityPLoS One.  13. 2018
2017 Mycoplasma hominis Infections Transmitted Through Amniotic Tissue ProductClinical Infectious Diseases.  65:1152-1158. 2017
2017 Beyond the uterine environment: A nonhuman primate model to investigate maternal-fetal and neonatal outcomes following chronic intrauterine infectionPediatric Research.  82:244-252. 2017
2017 New Horizons in Mycoplasma genitalium TreatmentJournal of Infectious Diseases.  216:S412-S419. 2017
2017 Mycoplasma pneumoniae from the respiratory tract and beyondClinical Microbiology Reviews.  30:747-809. 2017
2017 Sequelae of donor-derived mollicutes transmission in lung recipientsAmerican Journal of Respiratory and Critical Care Medicine.  195:687-689. 2017
2017 In vitro activities of lefamulin and other antimicrobial agents against macrolide-susceptible and macrolide-resistant Mycoplasma pneumoniae from the United States, Europe, and ChinaAntimicrobial Agents and Chemotherapy.  61. 2017
2017 Inter- and intra-strain variability of tandem repeats in Mycoplasma pneumoniae based on next-generation sequencing dataFuture Microbiology.  12:119-129. 2017
2017 Ureaplasma Transmitted From Donor Lungs Is Pathogenic After Lung TransplantationAnnals of Thoracic Surgery.  103:670-671. 2017
2017 Fluorocycline TP-271 is potent against complicated community-acquired bacterial pneumonia pathogensClinical and Vaccine Immunology.  2. 2017
2017 In vitro activities of gepotidacin (GSK2140944) and other antimicrobial agents against human mycoplasmas and ureaplasmasAntimicrobial Agents and Chemotherapy.  61. 2017
2017 Shaken or stirred?: Comparison of methods for dispersion of Mycoplasma pneumoniae aggregates for persistence in vivoJournal of Microbiological Methods.  132:56-62. 2017
2017 Ureaplasma infection-mediated release of matrix metalloproteinase-9 and PGP: A novel mechanism of preterm rupture of membranes and chorioamnionitisPediatric Research.  81:75-79. 2017
2016 In vitro activities of omadacycline (PTK 0796) and other antimicrobial agents against human mycoplasmas and ureaplasmasAntimicrobial Agents and Chemotherapy.  60:7502-7504. 2016
2016 Intra-amniotic ureaplasma parvum-induced maternal and fetal inflammation and immune responses in rhesus macaquesJournal of Infectious Diseases.  214:1597-1604. 2016
2015 Comparison of molecular characteristics of mycoplasma pneumonia specimens collected from the United States and ChinaJournal of Clinical Microbiology.  53:3891-3893. 2015
2015 Comparative genome analysis of Mycoplasma pneumoniaeBMC Genomics.  16. 2015
2015 Macrolide-resistant Mycoplasma pneumoniae, United States 2015
2015 Specificity and strain-typing capabilities of nanorod array-surface enhanced raman spectroscopy for Mycoplasma pneumoniae detectionPLoS One.  10. 2015
2015 Fusobacterium-Positive and Streptococcal-Positive PharyngitisACP journal club.  162:877-878. 2015
2015 Fusobacterium-positive and streptococcal-positive pharyngitisAnnals of Internal Medicine.  162:877-878. 2015
2015 Sore Throat: Avoid Overcomplicating the UncomplicatedACP journal club.  162:878. 2015
2015 Sore throat: Avoid overcomplicating the uncomplicatedAnnals of Internal Medicine.  162:878. 2015
2015 In Vitro antibacterial activity of AZD0914 against human mycoplasmas and ureaplasmasAntimicrobial Agents and Chemotherapy.  59:3627-3629. 2015
2015 Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humansScience Translational Medicine.  7:284ra59. 2015
2015 The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: A cross-sectional studyACP journal club.  162:241-247. 2015
2015 Contaminated open fracture and crush injury: A murine modelBone Research.  3. 2015
2015 Mycoplasma edwardii peritonitis in a patient on maintenance peritoneal dialysisClinical Nephrology.  83:45-48. 2015
2015 Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonizationAntimicrobial Agents and Chemotherapy.  59:570-578. 2015
2014 Comparison of the illumigene mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniaeJournal of Clinical Microbiology.  52:1060-1063. 2014
2014 Mycoplasma pneumoniae infections in childhood 2014
2014 Suppression of antimicrobial peptide expression by Ureaplasma speciesInfection and Immunity.  82:1657-1665. 2014
2014 Transplacental transfer of azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate modelJournal of Infectious Diseases.  209:898-904. 2014
2013 Helicobacter pylori infection inhibits phagocyte clearance of apoptotic gastric epithelial cellsJournal of Immunology.  190:6626-6634. 2013
2013 Azithromycin to prevent bronchopulmonary dysplasia in Ureaplasma-infected preterm infants: Pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous doseAntimicrobial Agents and Chemotherapy.  57:2127-2133. 2013
2013 Type 1 and type 2 strains of Mycoplasma pneumoniae form different biofilmsMicrobiology.  159:737-747. 2013
2013 Antimicrobial susceptibilities and treatment options for pediatric Mycoplasma pneumoniae infections - does macrolide resistance matter?Current Pediatric Reviews.  9:279-288. 2013
2012 Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticumJournal of Clinical Microbiology.  50:3542-3547. 2012
2012 Molecular methods for the detection of mycoplasma and ureaplasma infections in humans: A paper from the 2011 William Beaumont Hospital symposium on molecular pathology 2012
2012 Antimicrobial activity of PVP from an Antarctic bacterium, Janthinobacterium sp. Ant5-2, on multi-drug and methicillin resistant Staphylococcus aureusNatural Products and Bioprospecting.  2:104-110. 2012
2012 Comparative genome analysis of 19 Ureaplasma urealyticum and Ureaplasma parvum strainsBMC Microbiology.  12. 2012
2012 Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United StatesAntimicrobial Agents and Chemotherapy.  56:2780-2783. 2012
2012 Chronic rectal bleeding due to lymphogranuloma venereum proctocolitisAmerican Journal of Gastroenterology.  107:488-489. 2012
2012 Maternal azithromycin therapy for Ureaplasma intraamniotic infection delays preterm delivery and reduces fetal lung injury in a primate modelAmerican Journal of Obstetrics and Gynecology.  207:475.e1-475.e14. 2012
2011 What's new in diagnostic testing and treatment approaches for mycoplasma pneumoniae infections in children?Advances in Experimental Medicine and Biology.  719:47-57. 2011
2011 Genotypic characterization of Ureaplasma serovars from clinical isolates by pulsed-field gel electrophoresisJournal of Clinical Microbiology.  49:3325-3328. 2011
2011 Pharmacokinetics, safety, and biologic effects of azithromycin in extremely preterm infants at risk for ureaplasma colonization and bronchopulmonary dysplasiaJournal of Clinical Pharmacology.  51:1264-1275. 2011
2011 Extensive horizontal gene transfer in ureaplasmas from humans questions the utility of serotyping for diagnostic purposesJournal of Clinical Microbiology.  49:2818-2826. 2011
2011 Necrotizing enterocolitis is associated with ureaplasma colonization in preterm infantsPediatric Research.  69:442-447. 2011
2011 Mutations in ribosomal proteins and ribosomal RNA confer macrolide resistance in human Ureaplasma spp.International Journal of Antimicrobial Agents.  37:377-379. 2011
2011 Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia 2011
2011 Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumoniaPediatrics.  127. 2011
2011 Stromal regulation of human gastric dendritic cells restricts the Th1 response to helicobacter pyloriGastroenterology.  141:929-938. 2011
2010 Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniaePLoS One.  5. 2010
2010 Fusobacterium necrophorum bacteremic tonsillitis: 2 Cases and a review of the literatureAnaerobe.  16:626-628. 2010
2010 Detection of Mycoplasma pneumoniaein simulated and true clinical throat swab specimens by nanorod array-surface-enhanced raman spectroscopyPLoS One.  5. 2010
2010 The use of a biodegradable, load-bearing scaffold as a carrier for antibiotics in an infected open fracture modelJournal of Orthopaedic Trauma.  24:587-591. 2010
2010 Detection and characterization of human Ureaplasma species and serovars by real-time PCRJournal of Clinical Microbiology.  48:2715-2723. 2010
2010 Human primary gastric dendritic cells induce a Th1 response to H. pyloriMucosal Immunology.  3:260-269. 2010
2010 Evaluation of vancomycin and daptomycin potency trends (MIC Creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. Medical Centers from 2002 to 2006 (Antimicrobial Agents and Chemotherapy (2009) 53, 10, (4127-4132))Antimicrobial Agents and Chemotherapy.  54:1383. 2010
2009 Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. Medical Centers from 2002 to 2006Antimicrobial Agents and Chemotherapy.  53:4127-4132. 2009
2009 Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominisSeminars in Fetal and Neonatal Medicine.  14:190-199. 2009
2009 Corrigendum to "Multiple locus variable tandem repeats analysis of meticillin-resistant Staphylococcus aureus discriminates within USA pulsed-field gel electrophoresis types{star, open} [Journal of Hospital Infection 2009; 71: 333-339]" (DOI:10.1016/j.jhin.2008.12.011)Journal of Hospital Infection.  72:284. 2009
2009 Ureaplasma parvum as a cause of sternal wound infectionJournal of Clinical Microbiology.  47:1976-1978. 2009
2009 Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101Antimicrobial Agents and Chemotherapy.  53:2139-2141. 2009
2009 The role of Mycoplasma in upper respiratory infectionsCurrent Infectious Disease Reports.  11:198-206. 2009
2009 Emerging macrolide resistance in mycoplasma pneumoniae in children: Detection and characterization of resistant isolates 2009
2009 Multiple-locus variable-number tandem-repeat analysis of meticillin-resistant Staphylococcus aureus discriminates within USA pulsed-field gel electrophoresis typesJournal of Hospital Infection.  71:333-339. 2009
2009 Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaquesReproductive Sciences.  16:56-70. 2009
2008 New insights into the pathogenesis and detection of Mycoplasma pneumoniae infectionsFuture Microbiology.  3:635-648. 2008
2008 Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infectionsFEMS Microbiology Reviews.  32:956-973. 2008
2008 Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmasAntimicrobial Agents and Chemotherapy.  52:3776-3778. 2008
2008 Active surveillance to determine the impact of methicillin-resistant Staphylococcus aureus colonization on patients in intensive care units of a veterans affairs medical centerInfection Control and Hospital Epidemiology.  29:503-509. 2008
2008 Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studiesJournal of Hospital Infection.  68:208-213. 2008
2008 Dissemination of community-associated methicillin-resistant Staphylococcus aureus in a tertiary care hospitalSouthern Medical Journal.  101:40-45. 2008
2008 Genital tract methicillin-resistant Staphylococcus aureus: Risk of vertical transmission in pregnant womenObstetrics and Gynecology.  111:113-118. 2008
2008 Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccineJournal of Spinal Cord Medicine.  31:53-59. 2008
2007 USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infectionsJournal of Clinical Microbiology.  45:3431-3433. 2007
2007 Ureaplasma Infection and Neonatal Lung DiseaseSeminars in Perinatology.  31:2-9. 2007
2006 Genotypic characterization of Ureaplasma species by pulsed field gel electrophoresisJournal of Microbiological Methods.  67:606-610. 2006
2006 Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobialAntimicrobial Agents and Chemotherapy.  50:3479-3484. 2006
2006 Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical centerJournal of Clinical Microbiology.  44:3368-3370. 2006
2006 Prevalence of inducible clindamycin resistance among community- and hospital-associated Staphylococcus aureus isolatesJournal of Clinical Microbiology.  44:2481-2484. 2006
2006 Fluoroquinolone resistance in Ureaplasma parvum in the United StatesJournal of Clinical Microbiology.  44:1590-1591. 2006
2006 Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladderJournal of Spinal Cord Medicine.  29:217-226. 2006
2006 Influenza testing in the diagnostic laboratoryLaboratory Medicine.  37:366-370. 2006
2005 Mycoplasmas and ureaplasmas as neonatal pathogensClinical Microbiology Reviews.  18:757-789. 2005
2005 Characterization of ureaplasmas isolated from preterm infants with and without bronchopulmonary dysplasiaJournal of Clinical Microbiology.  43:4852-4854. 2005
2005 Comparative in vitro activities of investigational peptide deformylase inhibitor NVP LBM-415 and other agents against human mycoplasmas and ureaplasmasAntimicrobial Agents and Chemotherapy.  49:2541-2542. 2005
2005 Nosocomial ventriculitis due to Roseomonas gilardii complicating subarachnoid haemorrhageJournal of Infection.  50:244-251. 2005
2005 In vitro comparison of agar and microbroth dilution methods for determination of MICs for Mycoplasma hominisJournal of Microbiological Methods.  60:285-288. 2005
2005 Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infectionVaccine.  23:901-909. 2005
2005 Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques 2005
2005 Effective communication of antimicrobial susceptibility data by pathologists to cliniciansAdvances in Experimental Medicine and Biology.  563:165-177. 2005
2005 Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodiesJournal of Clinical Microbiology.  43:156-162. 2005
2005 Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae 2005
2004 Mycoplasma pneumoniae and its role as a human pathogenClinical Microbiology Reviews.  17:697-728. 2004
2004 Emerging intracellular bacterial infectionsClinics in Laboratory Medicine.  24:627-649. 2004
2004 The epidemiology of secondary conditions following spinal cord injuryTopics in Spinal Cord Injury Rehabilitation.  10:15-29. 2004
2004 Erratum: Antimicrobial resistance among isolates of respiratory tract infection pathogens from the southern United States: Data from the PROTEKT US surveillance program 2000/2001 (Southern Medical Journal (2003) 96, 10 (974-985))Southern Medical Journal.  97:230. 2004
2004 Effect of cranberry extract on bacteriuria and pyuria in persons with neurogenic bladder secondary to spinal cord injuryJournal of Spinal Cord Medicine.  27:35-40. 2004
2004 Microbiology of the urethra and perineum and its relationship to bacteriuria in community-residing men with spinal cord injury.Journal of Spinal Cord Medicine.  27:448-452. 2004
2003 Comparative In Vitro Susceptibilities and Bactericidal Activities of Investigational Fluoroquinolone ABT-492 and Other Antimicrobial Agents against Human Mycoplasmas and UreaplasmasAntimicrobial Agents and Chemotherapy.  47:3973-3975. 2003
2003 Dissemination of Macrolide-Resistant Streptococcus pneumoniae Isolates Containing Both erm(B) and mef(A) in South KoreaJournal of Clinical Microbiology.  41:5787-5791. 2003
2003 Antimicrobial Resistance among Isolates of Respiratory Tract Infection Pathogens from the Southern United States: Data from the PROTEKT US Surveillance Program 2000/2001Southern Medical Journal.  96:974-985. 2003
2003 New concepts of Mycoplasma pneumoniae infections in childrenPediatric pulmonology. Supplement.  36:267-278. 2003
2003 Bactericidal activity of levofloxacin against Mycoplasma pneumoniae [3]Journal of Antimicrobial Chemotherapy.  52:527-528. 2003
2003 Bacillus cereus bacteremia in a preterm neonateJournal of Clinical Microbiology.  41:3441-3444. 2003
2003 Genetic relatedness of levofloxacin-nonsusceptible Streptococcus pneumoniae isolates from North AmericaJournal of Clinical Microbiology.  41:2458-2464. 2003
2003 Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniaeInternational Journal of Antimicrobial Agents.  21:574-577. 2003
2003 Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: Findings of the PROTEKT surveillance studyDiagnostic Microbiology and Infectious Disease.  45:251-259. 2003
2003 Vancomycin-resistant enterococci: 15 years and countingJournal of Hospital Infection.  53:159-171. 2003
2003 Prevalence of plasmid-mediated quinolone resistanceAntimicrobial Agents and Chemotherapy.  47:559-562. 2003
2003 Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci. 2003
2003 In vitro activities of ABT-773 and other antimicrobials against human mycoplasmasAntimicrobial Agents and Chemotherapy.  47:39-42. 2003
2003 In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmasAntimicrobial Agents and Chemotherapy.  47:161-165. 2003
2003 Ligase chain reaction.Methods in Molecular Biology.  226:135-150. 2003
2002 Rhizobium radiobacter bacteremia and its detection in the clinical laboratoryClinical Microbiology Newsletter.  24:151-155. 2002
2002 In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobialsInternational Journal of Antimicrobial Agents.  20:136-140. 2002
2001 In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of childrenInternational Journal of Antimicrobial Agents.  18:531-535. 2001
2001 Evaluation of BacT/ALERT system for detection of Mycoplasma hominis in simulated blood culturesJournal of Clinical Microbiology.  39:4328-4331. 2001
2001 Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genesInternational Journal of Antimicrobial Agents.  18:373-378. 2001
2001 The value of culture and serology for detection of Mycoplasma pneumoniae infections in the clinical laboratory in the age of molecular diagnosticsClinical Microbiology Newsletter.  23:123-129. 2001
2001 Antimicrobial activities of gatifloxacin against nosocomial isolates of Stenotrophomonas maltophilia measured by MIC and time-kill studiesAntimicrobial Agents and Chemotherapy.  45:2126-2128. 2001
2001 Clones of Streptococcus pneumoniae isolated from nasopharyngeal carriage and invasive disease in young children in central TennesseeJournal of Infectious Diseases.  183:1501-1507. 2001
2001 Direct identification of Mycobacterium avium complex and Mycobacterium gordonae from MB/BacT bottles using accuprobeJournal of Clinical Microbiology.  39:570-573. 2001
2001 Bacteremia after spinal cord injury in initial versus subsequent hospitalizationsJournal of Spinal Cord Medicine.  24:96-100. 2001
2000 The MB/BacT is a sensitive method of isolating Mycobacterium tuberculosis from clinical specimens in a laboratory with a low rate of isolation [2] (multiple letters)Journal of Clinical Microbiology.  38:3133-3134. 2000
2000 Quantitative analysis of Helicobacter pylori infection in a mouse modelImmunotechnology : an international journal of immunological engineering.  242:67-78. 2000
2000 Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-γ, gene-deficient miceJournal of Immunology.  165:1022-1029. 2000
2000 Antimicrobial resistance in gram-negative bacteria isolated from the urinary tract in community-residing persons with spinal cord injury.Archives of Physical Medicine and Rehabilitation.  81:764-769. 2000
2000 Antimicrobial resistance in gram-negative bacteria isolated from the urinary tract in community-residing persons with spinal cord injuryArchives of Physical Medicine and Rehabilitation.  81:764-769. 2000
2000 Histologic examination of bone marrow core biopsy specimens has limited value in the diagnosis of mycobacterial and fungal infections in patients with the acquired immunodeficiency syndromeAnnals of Diagnostic Pathology.  4:1-6. 2000
2000 Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and childrenJournal of Clinical Microbiology.  38:1731-1734. 2000
1999 Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical CenterSexually Transmitted Diseases.  26:496-499. 1999
1999 Comparison of microscan MICroSTREP, PASCO, and sensititre MIC panels for determining antimicrobial susceptibilities of Streptococcus pneumoniaeDiagnostic Microbiology and Infectious Disease.  33:267-273. 1999
1999 Comparison of direct inoculation and Copan transport systems for isolation of Neisseria gonorrhoeae from endocervical specimensJournal of Clinical Microbiology.  37:3583-3585. 1999
1999 Detection of Chlamydia trachomatis endocervical infections by ligase chain reaction versus ACCESS Chlamydia antigen assayJournal of Clinical Microbiology.  37:3072-3073. 1999
1999 Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injuryJournal of Spinal Cord Medicine.  22:192-198. 1999
1999 In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E testAntimicrobial Agents and Chemotherapy.  43:2571-2573. 1999
1999 No relationship between gastric pH, small bowel bacterial colonisation, and diarrhoea in HIV-1 infected patientsGut.  44:101-105. 1999
1998 Direct bacterial identification from positive BacT/Alert blood cultures using MicroScan overnight and rapid panelsDiagnostic Microbiology and Infectious Disease.  32:21-26. 1998
1998 Comparative in vitro activities of four new fluoroquinolones against Streptococcus pneumoniae determined by EtestInternational Journal of Antimicrobial Agents.  9:215-218. 1998
1998 The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infectionsAmerican Journal of Medicine.  104:123-128. 1998
1998 Association rules and data mining in hospital infection control and public health surveillanceJournal of the American Medical Informatics Association.  5:373-381. 1998
1998 Bactericidal activities of ceftizoxime and cefotaxime against Streptococcus pneumoniae [3] (multiple letters)Antimicrobial Agents and Chemotherapy.  42:1869-1870. 1998
1998 Bone marrow biopsy and blood culture in evaluating HIV patients [5] (multiple letters)American Journal of Medicine.  105:457-458. 1998
1998 Comparison of the MB/BacT system with a revised antibiotic supplement kit to the BACTEC 460 system for detection of mycobacteria in clinical specimensJournal of Clinical Microbiology.  36:3234-3238. 1998
1998 Comparison of two rapid latex agglutination tests for detection of cryptococcal capsular polysaccharideAmerican Journal of Clinical Pathology.  109:634-641. 1998
1998 Direct susceptibility testing with positive BacT/Alert blood cultures by using MicroScan overnight and rapid panelsJournal of Clinical Microbiology.  36:2052-2056. 1998
1998 Identification of oxacillin-susceptible and oxacillin-resistant Staphylococcus aureus using commercial latex agglutination testsDiagnostic Microbiology and Infectious Disease.  30:131-134. 1998
1998 Immunogenicity of pneumococcal vaccine in persons with spinal cord injuryArchives of Physical Medicine and Rehabilitation.  79:1504-1509. 1998
1998 Research Paper: Association Rules and Data Mining in Hospital Infection Control and Public Health Surveillance. 1998
1997 Spontaneously Colitic C3H/HeJBir Mice Demonstrate Selective Antibody Reactivity to Antigens of the Enteric Bacterial FloraJournal of Immunology.  159:44-52. 1997
1997 In vitro activities of cefepime versus cefotaxime and ceftriaxone against penicillin-resistant Streptococcus pneumoniae determined by EtestInternational Journal of Antimicrobial Agents.  9:137-138. 1997
1997 Evaluation of the etest for detection of tetracycline resistance in mycoplasma hominisDiagnostic Microbiology and Infectious Disease.  27:117-122. 1997
1997 Microbiology testing and the pediatrician's office 1997
1997 Development of a reverse transcription-polymerase chain reaction assay for diagnosis of lymphocytic choriomeningitis virus infection and its use in a prospective surveillance studyJournal of Medical Virology.  51:107-114. 1997
1997 Development of a reverse transcription-polymerase chain reaction assay for diagnosis of lymphocytic choriomeningitis virus infection and its use in a prospective surveillance study.Journal of Medical Virology.  51:107-114. 1997
1997 Age distribution of lymphocytic choriomeningitis virus serum antibody in Birmingham, Alabama: Evidence of a decreased risk of infectionAmerican Journal of Tropical Medicine and Hygiene.  57:37-41. 1997
1997 Clinical applications of C-reactive protein in pediatrics 1997
1997 Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinationsAntimicrobial Agents and Chemotherapy.  41:881-885. 1997
1997 Comparison of long-term renal function after spinal cord injury using different urinary management methodsArchives of Physical Medicine and Rehabilitation.  78:992-997. 1997
1997 Detection of Kingella kingae bacteremia and identification of the organism in the clinical laboratory: Experience from two casesClinical Microbiology Newsletter.  19:73-76. 1997
1997 Genotypic investigation of multidrug-resistant Acinetobacter baumannii infections in a medical intensive care unitJournal of Hospital Infection.  37:125-135. 1997
1997 In vitro activities of oral antimicrobial agents against penicillin- resistant Streptococcus pneumoniae: Implications for outpatient treatmentSouthern Medical Journal.  90:621-626. 1997
1997 Predicting compliance with annual follow-up evaluations in persons with spinal cord injurySpinal Cord.  35:314-319. 1997
1996 Comparative activities of parenteral cephalosporins against penicillin-resistant Streptococcus pneumoniae isolated from pediatric patients 1996
1996 Detection of oxacillin-resistance in staphylococcus aureus by MicroScan MIC panels in comparison to four other methodsDiagnostic Microbiology and Infectious Disease.  24:93-100. 1996
1996 In vitro activities of parenteral cephalosporins against penicillin-resistant Streptococcus pneumoniae isolated from pediatric patientsJournal of Investigative Medicine.  44. 1996
1996 Is sterile water necessary in the water bottle for endoscopic procedures: A prospective clinical and microbiological studyGastrointestinal Endoscopy.  43:323. 1996
1996 Laboratory diagnosis of mycoplasmal and ureaplasmal infectionsClinical Microbiology Newsletter.  18:105-112. 1996
1996 Use of sterile compared with tap water in gastrointestinal endoscopic proceduresAmerican Journal of Infection Control.  24:407-410. 1996
1995 When to use fluconazole 1995
1995 When to use fluconazole 1995
1995 Compliance with annual urologic evaluations and preservation of renal function in persons with spinal cord injury.Journal of Spinal Cord Medicine.  18:251-254. 1995
1995 Isolation of Ureaplasma urealyticum from low birth weight infantsJournal of Pediatrics.  126:502. 1995
1994 Erythromycin lactobionate toxicity in preterm neonates 1994
1994 Multicenter in vitro comparative study of fluoroquinolones after four years of widespread clinical useDiagnostic Microbiology and Infectious Disease.  18:181-189. 1994
1994 Phagocytosis of urinary pathogens in persons with spinal cord injuryArchives of Physical Medicine and Rehabilitation.  75:63-66. 1994
1994 Pulmonary infection due to legionella cincinnatiensis in renal transplant recipients: Two cases and implications for laboratory diagnosisClinical Infectious Diseases.  18:385-389. 1994
1994 Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection 1994
1993 A quantitative study of genital skin flora in male spinal cord-injured outpatientsAmerican Journal of Physical Medicine and Rehabilitation.  72:117-121. 1993
1993 Epidemiology and risk factors for urinary tract infection following spinal cord injuryArchives of Physical Medicine and Rehabilitation.  74:691-695. 1993
1993 Eradication of urinary tract infection following spinal cord injurySpinal Cord.  31:645-652. 1993
1993 Radiographic Changes Associated with Tracheal Isolation of Ureaplasma Urealyticum from NeonatesClinical Infectious Diseases.  17:S122-S130. 1993
1993 Spinal osteomyelitis due to mycobacterium avium-intracellulare in an elderly man with steroid-induced osteoporosisSpine.  18:1926-1932. 1993
1993 Systemic Neonatal Infection Due to Ureaplasma urealyticumClinical Infectious Diseases.  17:S131-S135. 1993
1993 Therapeutic Considerations for Ureaplasma urealyticum Infections in NeonatesClinical Infectious Diseases.  17:S208-S214. 1993
1993 Ureaplasma urealyticum intrauterine infection: Role in prematurity and disease in newbornsClinical Microbiology Reviews.  6:69-87. 1993
1992 Antibiotic susceptibilities and therapeutic options for ureaplasma urealyticum infections in neonates 1992
1992 Serotype diversity and antigen variation among invasive isolates of Ureaplasma urealyticum from neonatesInfection and Immunity.  60:3472-3474. 1992
1991 Efficacy of clarithromycin against Mycoplasma pneumoniae.Journal of Antimicrobial Chemotherapy.  27 Suppl A:47-59. 1991
1991 Comparison of agar versus broth dilution techniques for determining antibiotic susceptibilities of Ureaplasma urealyticumDiagnostic Microbiology and Infectious Disease.  14:265-271. 1991
1991 Efficacy and tolerance of norfloxacinin treatment of complicated urinary tract infection in outpatients with neurogenic bladder secondary to spinal cord injuryUrology.  38:589-596. 1991
1991 In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391Antimicrobial Agents and Chemotherapy.  35:1181-1185. 1991
1991 Mycoplasmal infections of cerebrospinal fluid in children undergoing neurosurgery for hydrocephalus 1991
1991 Neurogenic urinary tract infectionNeurologic Clinics.  9:741-755. 1991
1991 Perinatal mycoplasmal infectionsClinics in Perinatology.  18:241-262. 1991
1991 The effects of three serotypes of Ureaplasma urealyticum on spermatozoal motility and penetration in vitroFertility and Sterility.  55:170-176. 1991
1991 [525] Pathologic effects of recurrent bacteriuria in patients with spinal cord dysfunctionBulletin of prosthetics research.  28:417-418. 1991
1990 Ureaplasma and mycoplasma CNS infections in newborn babies 1990
1990 Hyperoxia potentiates Ureaplasma urealyticum pneumonia in newborn miceInfection and Immunity.  58:3487-3493. 1990
1990 Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population 1990
1990 Norfloxacin treatment of nosocomial urinary tract infection in patients undergoing intermittent catheterization following spinal cord injury 1990
1989 Comparative susceptibility of Mycoplasma pneumoniae to erythromycin, ciprofloxacin, and lomefloxacinDiagnostic Microbiology and Infectious Disease.  12:433-435. 1989
1989 Ureaplasma urealyticum infectionBiomedicine and Pharmacotherapy.  43:627. 1989
1989 Ureaplasma urealyticum pneumonia: Experimental production and demonstration of age-related susceptibilityInfection and Immunity.  57:918-925. 1989
1989 Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newbornPediatrics.  83:79-85. 1989
1989 Urinary tract infection in spinal cord injuryArchives of Physical Medicine and Rehabilitation.  70:47-54. 1989
1988 Comparative in vitro activity of norfloxacin in gram-negative urinary tract infections following spinal cord injury 1988
1988 Does Ureaplasma urealyticum cause respiratory disease in newborns? 1988
1988 Genital Mycoplasma infections in neonatesJournal of Pediatrics.  112:167-168. 1988
1988 In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolonesAntimicrobial Agents and Chemotherapy.  32:1500-1502. 1988
1987 Isolation of Acholeplasma oculi from human amniotic fluid in early pregnancy 1987
1987 Chronic Recurrent Multifocal Osteomyelitis: Are Mycoplasmas Involved?New England Journal of Medicine.  317:510-511. 1987
1987 Pathogenesis and significance of urogenital mycoplasmal infections.Advances in Experimental Medicine and Biology.  224:93-115. 1987
1986 Role of Ureaplasma urealyticum in amnionitis. 1986
1986 Role of ureaplasma urealyticum in amnionitis 1986
1986 Ureaplasma urealyticum and its possible role in pneumonia during the neonatal period and infancy 1986
1986 Ureaplasma urealyticum and its possible role in pneumonia during the neonatal period and infancy. 1986
1985 Ureaplasma urealyticum polyarthritis in agammaglobulinemia 1985
1984 Clinically silent polymicrobial amnionitis and intrauterine fetal death associated with a Cu-7 intrauterine contraceptive deviceAmerican Journal of Obstetrics and Gynecology.  150:998-999. 1984
1983 Association of genital mycoplasmas with exudative vaginitis in a 10-year-old: A case of misdiagnosisPediatrics.  71:250-252. 1983
1983 Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy.Sexually Transmitted Diseases.  10:294-302. 1983
1983 Isolation of mycoplasma hominis and ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: Potential effect on outcome of pregnancySexually Transmitted Diseases.  10:294-302. 1983


Year Title Altmetric
2019 Medically relevant.  28-38. 2019
2015 Mycoplasma.  1076-1085. 2015
2014 Mycoplasmas and Ureaplasmas of Humans.  1587-1609. 2014
2013 Mycoplasma: Curiosity and pathogen.  308-313. 2013
2013 Mycoplasma and ureaplasma.  229-281. 2013
2012 Mycoplasma: Curiosity and pathogen.  308-313. 2012
2011 Ureaplasma.  469-487. 2011
2010 Mycoplasma.  1145-1156. 2010
2009 Mycoplasma pneumoniae and other human mycoplasmas.  519-541. 2009

Principal Investigator On

  • Azithromycin to Prevent BPD in Ureaplasma-Infected Preterms: A Multi-Dose PK and Efficacy Trial  awarded by UNIVERSITY OF MARYLAND (BALTIMORE)
  • Comparison Of Commercially Available Diagnostics For The Detection Of Mycoplasma Pneumoniae, Including Macrolide Resistance Determination  awarded by CDC - Centers for Disease Control and Prevention/DHHS
  • Host-Microbe Cross-Talk and Pregnancy Outcomes  awarded by CINCINNATI CHILDREN'S HOSPITAL
  • Molecular Epidemiology, Virulence, and Genomic Characterization of Ureaplasmas  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Primate Model of Mid-Gestation Ureaplasma in Utero Infection: Prevention of Neurologic Sequelae  awarded by Oregon Health & Science University
  • Private Grant  awarded by MERIDIAN BIOSCIENCE INC.
  • Private Grant  awarded by CEMPRA PHARMACEUTICALS, INC.
  • Private Grant  awarded by ASTRAZENECA UK LTD
  • Private Grant  awarded by CEMPRA PHARMACEUTICALS, INC.
  • Private Grant  awarded by NABRIVA THERAPEUTICS AG
  • Private Grant  awarded by PARATEK PHARMACEUTICALS, LLC.
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by IHMA, INC.
  • Private Grant  awarded by WOCKHARDT LTD/PPD
  • Sentinel Surveillance for Macrollde-Reslstant Mycoplasma Pneumonlae at Select Sites In the United States  awarded by CDC - Centers for Disease Control and Prevention/DHHS
  • Supplement to Aetiology of Neonatal Infection in South Asia: Development of a Community-Based Presumptive Clinical Diagnosis Algorithm and Treatment Regimen for Maternal Puerperal Sepsis.  awarded by THE BANGLADESH CHILD HEALTH RESEARCH FOUNDATION
  • Education And Training

  • UAB Hospital, Internship
  • UAB Hospital, Residency
  • Full Name

  • Ken Waites